Department of Urology, Faculty of Medicine, University of Freiburg Medical Centre, Freiburg, Germany.
Department of Urology, Faculty of Medicine, University of Freiburg Medical Centre, Freiburg, Germany.
Eur Urol Focus. 2022 Mar;8(2):425-430. doi: 10.1016/j.euf.2021.03.025. Epub 2021 Apr 12.
This case series highlights the role of repeat salvage lymph node dissection (sLND) for nodal-recurrent prostate cancer. We provide a descriptive analysis of ten patients who underwent sLND in a total of 23 surgeries (mean 2.3 sLNDs per patient) and their long-term follow-up (median of 158 mo after radical prostatectomy). A complete prostate-specific antigen response was observed in nine/23 cases (39.1%), and an incomplete response in 14 (60.9%). Analysis by anatomical location revealed a trend towards more distant metastases on repeat surgery, with only three in-field recurrences in patients with previously positive nodes. Repeat sLND can be surgically challenging, and major intraoperative complications were observed in three/23 cases (13.0%). Repeat sLND for patients with nodal-recurrent prostate cancer seems to be a feasible treatment option, albeit only in carefully selected patients. Nevertheless, it remains a highly experimental approach with unclear oncological benefit.
本病例系列强调了重复挽救性淋巴结清扫术 (sLND) 在淋巴结复发性前列腺癌中的作用。我们对 10 名患者进行了描述性分析,这些患者共进行了 23 次手术 (每位患者平均进行 2.3 次 sLND),并对他们进行了长期随访 (根治性前列腺切除术后中位数为 158 个月)。在 23 例中有 9 例 (39.1%) 观察到完全前列腺特异性抗原反应,14 例 (60.9%) 观察到不完全反应。按解剖部位分析,重复手术时远处转移的趋势更为明显,先前淋巴结阳性的患者中只有 3 例为局部复发。重复 sLND 手术具有挑战性,在 23 例中有 3 例 (13.0%) 发生重大术中并发症。对于淋巴结复发性前列腺癌患者,重复 sLND 似乎是一种可行的治疗选择,但仅适用于精心挑选的患者。然而,它仍然是一种高度实验性的方法,其肿瘤学获益尚不清楚。